메뉴 건너뛰기




Volumn 85, Issue 11, 2013, Pages 1700-1711

Agonism of human pregnane X receptor by rilpivirine and etravirine: Comparison with first generation non-nucleoside reverse transcriptase inhibitors

Author keywords

Delavirdine; Efavirenz; Etravirine; Nevirapine; Pregnane; Rilpivirine; X receptor

Indexed keywords

CYTOCHROME P450 3A4; DELAVIRDINE; EFAVIRENZ; ETRAVIRINE; GREEN FLUORESCENT PROTEIN; NEVIRAPINE; NUCLEAR RECEPTOR COACTIVATOR 2; PREGNANE X RECEPTOR; RILPIVIRINE; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR COACTIVATOR 3;

EID: 84877590011     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.04.002     Document Type: Article
Times cited : (36)

References (57)
  • 1
    • 36749088862 scopus 로고    scopus 로고
    • HIV drug development: The next 25 years
    • C. Flexner HIV drug development: the next 25 years Nat Rev Drug Discov 6 2007 959 966
    • (2007) Nat Rev Drug Discov , vol.6 , pp. 959-966
    • Flexner, C.1
  • 2
    • 84872905207 scopus 로고    scopus 로고
    • Quality of life of people living with HIV and AIDS and antiretroviral therapy
    • O.O. Oguntibeju Quality of life of people living with HIV and AIDS and antiretroviral therapy HIV AIDS 4 2012 117 124
    • (2012) HIV AIDS , vol.4 , pp. 117-124
    • Oguntibeju, O.O.1
  • 3
    • 84870202766 scopus 로고    scopus 로고
    • New therapeutic landscape of NNRTIs for treatment of HIV: A look at recent data
    • D. Jayaweera, and P. Dilanchian New therapeutic landscape of NNRTIs for treatment of HIV: a look at recent data Expert Opin Pharmacother 13 2012 2601 2612
    • (2012) Expert Opin Pharmacother , vol.13 , pp. 2601-2612
    • Jayaweera, D.1    Dilanchian, P.2
  • 4
    • 84861977399 scopus 로고    scopus 로고
    • When rilpivirine meets with tenofovir, the start of a new anti-HIV drug combination era
    • E. De Clercq When rilpivirine meets with tenofovir, the start of a new anti-HIV drug combination era Biochem Pharmacol 84 2012 241 248
    • (2012) Biochem Pharmacol , vol.84 , pp. 241-248
    • De Clercq, E.1
  • 5
    • 61449189645 scopus 로고    scopus 로고
    • Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV
    • E. De Clercq Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV Int J Antimicrob Agents 33 2009 307 320
    • (2009) Int J Antimicrob Agents , vol.33 , pp. 307-320
    • De Clercq, E.1
  • 6
    • 84859920508 scopus 로고    scopus 로고
    • Etravirine: A review of its use in the management of treatment- experienced patients with HIV-1 infection
    • J.D. Croxtall Etravirine: a review of its use in the management of treatment-experienced patients with HIV-1 infection Drugs 72 2012 847 869
    • (2012) Drugs , vol.72 , pp. 847-869
    • Croxtall, J.D.1
  • 7
    • 37349114118 scopus 로고    scopus 로고
    • Nuclear receptors: Decoding metabolic disease
    • J. Sonoda, L. Pei, and R.M. Evans Nuclear receptors: decoding metabolic disease FEBS Lett 582 2008 2 9
    • (2008) FEBS Lett , vol.582 , pp. 2-9
    • Sonoda, J.1    Pei, L.2    Evans, R.M.3
  • 9
    • 0035805536 scopus 로고    scopus 로고
    • Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin
    • A. Geick, M. Eichelbaum, and O. Burk Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin J Biol Chem 276 2001 14581 14587
    • (2001) J Biol Chem , vol.276 , pp. 14581-14587
    • Geick, A.1    Eichelbaum, M.2    Burk, O.3
  • 10
    • 0037169551 scopus 로고    scopus 로고
    • Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor
    • H.R. Kast, B. Goodwin, P.T. Tarr, S.A. Jones, A.M. Anisfeld, and C.M. Stoltz Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor J Biol Chem 277 2002 2908 2915
    • (2002) J Biol Chem , vol.277 , pp. 2908-2915
    • Kast, H.R.1    Goodwin, B.2    Tarr, P.T.3    Jones, S.A.4    Anisfeld, A.M.5    Stoltz, C.M.6
  • 13
    • 0032169485 scopus 로고    scopus 로고
    • The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions
    • J.M. Lehmann, D.D. McKee, M.A. Watson, T.M. Willson, J.T. Moore, and S.A. Kliewer The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions J Clin Invest 102 1998 1016 1023
    • (1998) J Clin Invest , vol.102 , pp. 1016-1023
    • Lehmann, J.M.1    McKee, D.D.2    Watson, M.A.3    Willson, T.M.4    Moore, J.T.5    Kliewer, S.A.6
  • 17
    • 84862813487 scopus 로고    scopus 로고
    • Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters
    • Y. Chen, Y. Tang, C. Guo, J. Wang, D. Boral, and D. Nie Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters Biochem Pharmacol 83 2012 1112 1126
    • (2012) Biochem Pharmacol , vol.83 , pp. 1112-1126
    • Chen, Y.1    Tang, Y.2    Guo, C.3    Wang, J.4    Boral, D.5    Nie, D.6
  • 18
    • 79959548856 scopus 로고    scopus 로고
    • Nuclear receptors CAR and PXR: Therapeutic targets for cholestatic liver disease
    • S. Kakizaki, D. Takizawa, H. Tojima, N. Horiguchi, Y. Yamazaki, and M. Mori Nuclear receptors CAR and PXR: therapeutic targets for cholestatic liver disease Front Biosci 17 2011 2988 3005
    • (2011) Front Biosci , vol.17 , pp. 2988-3005
    • Kakizaki, S.1    Takizawa, D.2    Tojima, H.3    Horiguchi, N.4    Yamazaki, Y.5    Mori, M.6
  • 20
    • 84866738222 scopus 로고    scopus 로고
    • Targeting xenobiotic receptors PXR and CAR for metabolic diseases
    • J. Gao, and W. Xie Targeting xenobiotic receptors PXR and CAR for metabolic diseases Trends Pharmacol Sci 33 2012 552 558
    • (2012) Trends Pharmacol Sci , vol.33 , pp. 552-558
    • Gao, J.1    Xie, W.2
  • 21
    • 6344240478 scopus 로고    scopus 로고
    • Induction of CYP3A4 by efavirenz in primary human hepatocytes: Comparison with rifampin and phenobarbital
    • N. Hariparsad, S.C. Nallani, R.S. Sane, D.J. Buckley, A.R. Buckley, and P.B. Desai Induction of CYP3A4 by efavirenz in primary human hepatocytes: Comparison with rifampin and phenobarbital J Clin Pharmacol 44 2004 1273 1281
    • (2004) J Clin Pharmacol , vol.44 , pp. 1273-1281
    • Hariparsad, N.1    Nallani, S.C.2    Sane, R.S.3    Buckley, D.J.4    Buckley, A.R.5    Desai, P.B.6
  • 22
    • 33845881481 scopus 로고    scopus 로고
    • Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers
    • S.R. Faucette, T.C. Zhang, R. Moore, T. Sueyoshi, C.J. Omiecinski, and E.L. LeCluyse Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers J Pharmacol Exp Ther 320 2007 72 80
    • (2007) J Pharmacol Exp Ther , vol.320 , pp. 72-80
    • Faucette, S.R.1    Zhang, T.C.2    Moore, R.3    Sueyoshi, T.4    Omiecinski, C.J.5    Lecluyse, E.L.6
  • 23
    • 78650210692 scopus 로고    scopus 로고
    • Nuclear receptor-mediated induction of CYP450 by antiretrovirals: Functional consequences of NR1I2 (PXR) polymorphisms and differential prevalence in whites and sub-Saharan Africans
    • J. Svard, J.P. Spiers, F. Mulcahy, and M. Hennessy Nuclear receptor-mediated induction of CYP450 by antiretrovirals: Functional consequences of NR1I2 (PXR) polymorphisms and differential prevalence in whites and sub-Saharan Africans J Acquir Immune Defic Syndr 55 2010 536 549
    • (2010) J Acquir Immune Defic Syndr , vol.55 , pp. 536-549
    • Svard, J.1    Spiers, J.P.2    Mulcahy, F.3    Hennessy, M.4
  • 24
    • 84858394506 scopus 로고    scopus 로고
    • Biotransformation of the antiretroviral drug etravirine: Metabolite identification, reaction phenotyping, and characterization of autoinduction of cytochrome P450-dependent metabolism
    • L.J. Yanakakis, and N.N. Bumpus Biotransformation of the antiretroviral drug etravirine: Metabolite identification, reaction phenotyping, and characterization of autoinduction of cytochrome P450-dependent metabolism Drug Metab Dispos 40 2012 803 814
    • (2012) Drug Metab Dispos , vol.40 , pp. 803-814
    • Yanakakis, L.J.1    Bumpus, N.N.2
  • 25
    • 33845904129 scopus 로고    scopus 로고
    • The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor
    • C. Zhou, E.J. Poulton, F. Grun, T.K. Bammler, B. Blumberg, and K.E. Thummel The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor Mol Pharmacol 71 2007 220 229
    • (2007) Mol Pharmacol , vol.71 , pp. 220-229
    • Zhou, C.1    Poulton, E.J.2    Grun, F.3    Bammler, T.K.4    Blumberg, B.5    Thummel, K.E.6
  • 26
    • 17744375160 scopus 로고    scopus 로고
    • The Pregnane X receptor: A promiscuous xenobiotic receptor that has diverged during evolution
    • S.A. Jones, L.B. Moore, J.L. Shenk, G.B. Wisely, G.A. Hamilton, and D.D. McKee The Pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution Mol Endocrinol 14 2000 27 39
    • (2000) Mol Endocrinol , vol.14 , pp. 27-39
    • Jones, S.A.1    Moore, L.B.2    Shenk, J.L.3    Wisely, G.B.4    Hamilton, G.A.5    McKee, D.D.6
  • 27
    • 0032702726 scopus 로고    scopus 로고
    • The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module
    • B. Goodwin, E. Hodgson, and C. Liddle The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module Mol Pharmacol 56 1999 1329 1339
    • (1999) Mol Pharmacol , vol.56 , pp. 1329-1339
    • Goodwin, B.1    Hodgson, E.2    Liddle, C.3
  • 28
    • 78649617185 scopus 로고    scopus 로고
    • Human pregnane X receptor agonism by Ginkgo biloba extract: Assessment of the role of individual ginkgolides
    • A.J. Lau, G. Yang, G. Rajaraman, C.C. Baucom, and T.K.H. Chang Human pregnane X receptor agonism by Ginkgo biloba extract: Assessment of the role of individual ginkgolides J Pharmacol Exp Ther 335 2010 771 780
    • (2010) J Pharmacol Exp Ther , vol.335 , pp. 771-780
    • Lau, A.J.1    Yang, G.2    Rajaraman, G.3    Baucom, C.C.4    Chang, T.K.H.5
  • 29
    • 80054791510 scopus 로고    scopus 로고
    • Isoform-selective activation of human constitutive androstane receptor by Ginkgo biloba extract: Functional analysis of the SV23, SV24, and SV25 splice variants
    • A.J. Lau, G. Yang, and T.K.H. Chang Isoform-selective activation of human constitutive androstane receptor by Ginkgo biloba extract: functional analysis of the SV23, SV24, and SV25 splice variants J Pharmacol Exp Ther 339 2011 704 715
    • (2011) J Pharmacol Exp Ther , vol.339 , pp. 704-715
    • Lau, A.J.1    Yang, G.2    Chang, T.K.H.3
  • 30
    • 84862081533 scopus 로고    scopus 로고
    • Selective agonism of human pregnane X receptor by individual ginkgolides
    • A.J. Lau, G. Yang, C.W. Yap, and T.K.H. Chang Selective agonism of human pregnane X receptor by individual ginkgolides Drug Metab Dispos 40 2012 1113 1121
    • (2012) Drug Metab Dispos , vol.40 , pp. 1113-1121
    • Lau, A.J.1    Yang, G.2    Yap, C.W.3    Chang, T.K.H.4
  • 31
    • 0019768156 scopus 로고
    • Trypan blue dye uptake and lactate dehydrogenase in adult rat hepatocytes - Freshly isolated cells, cell suspensions, and primary monolayer cultures
    • H.O. Jauregui, N.T. Hayner, J.L. Driscoll, R. Williams-Holland, M.H. Lipsky, and P.M. Galletti Trypan blue dye uptake and lactate dehydrogenase in adult rat hepatocytes - freshly isolated cells, cell suspensions, and primary monolayer cultures In Vitro 17 1981 1100 1110
    • (1981) In Vitro , vol.17 , pp. 1100-1110
    • Jauregui, H.O.1    Hayner, N.T.2    Driscoll, J.L.3    Williams-Holland, R.4    Lipsky, M.H.5    Galletti, P.M.6
  • 32
    • 0025134337 scopus 로고
    • Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes
    • L. Pichard, I. Fabre, G. Fabre, J. Domergue, B. Saint Aubert, and G. Mourad Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes Drug Metab Dispos 18 1990 595 606
    • (1990) Drug Metab Dispos , vol.18 , pp. 595-606
    • Pichard, L.1    Fabre, I.2    Fabre, G.3    Domergue, J.4    Saint Aubert, B.5    Mourad, G.6
  • 33
    • 0030059953 scopus 로고    scopus 로고
    • Modulators and substrates of P-glycoprotein and cytochrome P450 3A coordinately up-regulate these proteins in human colon carcinoma cells
    • E.G. Schuetz, W.T. Beck, and J.D. Schuetz Modulators and substrates of P-glycoprotein and cytochrome P450 3A coordinately up-regulate these proteins in human colon carcinoma cells Mol Pharmacol 49 1996 311 318
    • (1996) Mol Pharmacol , vol.49 , pp. 311-318
    • Schuetz, E.G.1    Beck, W.T.2    Schuetz, J.D.3
  • 34
    • 34248596312 scopus 로고    scopus 로고
    • Gene expression of HIF-1α and XRCC4 measured in human samples by real-time RT-PCR using the sigmoidal curve-fitting method
    • H. Qiu, K. Durand, H. Rabinovitch-Chable, M. Rigaud, V. Gazaille, and P. Clavere Gene expression of HIF-1α and XRCC4 measured in human samples by real-time RT-PCR using the sigmoidal curve-fitting method Biotechniques 42 2007 355 362
    • (2007) Biotechniques , vol.42 , pp. 355-362
    • Qiu, H.1    Durand, K.2    Rabinovitch-Chable, H.3    Rigaud, M.4    Gazaille, V.5    Clavere, P.6
  • 35
    • 31344477335 scopus 로고    scopus 로고
    • Distinct role of bilobalide and ginkgolide A in the modulation of rat CYP2B1 and CYP3A23 gene expression by Ginkgo biloba extract in cultured hepatocytes
    • T.K.H. Chang, J. Chen, and X.W. Teng Distinct role of bilobalide and ginkgolide A in the modulation of rat CYP2B1 and CYP3A23 gene expression by Ginkgo biloba extract in cultured hepatocytes Drug Metab Dispos 34 2006 234 242
    • (2006) Drug Metab Dispos , vol.34 , pp. 234-242
    • Chang, T.K.H.1    Chen, J.2    Teng, X.W.3
  • 36
    • 73349087148 scopus 로고    scopus 로고
    • Activation of pregnane X receptor (PXR) and constitutive androstane receptor (CAR) by herbal medicines
    • T.K.H. Chang Activation of pregnane X receptor (PXR) and constitutive androstane receptor (CAR) by herbal medicines AAPS J 11 2009 590 601
    • (2009) AAPS J , vol.11 , pp. 590-601
    • Chang, T.K.H.1
  • 37
    • 0034685779 scopus 로고    scopus 로고
    • Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands
    • L.B. Moore, D.J. Parks, S.A. Jones, R.K. Bledsoe, T.G. Consler, and J.B. Stimmel Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands J Biol Chem 275 2000 15122 15127
    • (2000) J Biol Chem , vol.275 , pp. 15122-15127
    • Moore, L.B.1    Parks, D.J.2    Jones, S.A.3    Bledsoe, R.K.4    Consler, T.G.5    Stimmel, J.B.6
  • 38
    • 0037333974 scopus 로고    scopus 로고
    • Molecular mechanism of nuclear translocation of an orphan nuclear receptor, SXR
    • K. Kawana, T. Ikuta, Y. Kobayashi, O. Gotoh, K. Takeda, and K. Kawajiri Molecular mechanism of nuclear translocation of an orphan nuclear receptor, SXR Mol Pharmacol 63 2003 524 531
    • (2003) Mol Pharmacol , vol.63 , pp. 524-531
    • Kawana, K.1    Ikuta, T.2    Kobayashi, Y.3    Gotoh, O.4    Takeda, K.5    Kawajiri, K.6
  • 39
    • 70349308415 scopus 로고    scopus 로고
    • A systematic analysis of predicted phosphorylation sites within the human pregnane X receptor protein
    • K. Lichti-Kaiser, D. Brobst, C. Xu, and J.L. Staudinger A systematic analysis of predicted phosphorylation sites within the human pregnane X receptor protein J Pharmacol Exp Ther 331 2009 65 76
    • (2009) J Pharmacol Exp Ther , vol.331 , pp. 65-76
    • Lichti-Kaiser, K.1    Brobst, D.2    Xu, C.3    Staudinger, J.L.4
  • 40
    • 0036893593 scopus 로고    scopus 로고
    • Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions
    • R. Yuan, S. Madani, X.X. Wei, K. Reynolds, and S.M. Huang Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions Drug Metab Dispos 30 2002 1311 1319
    • (2002) Drug Metab Dispos , vol.30 , pp. 1311-1319
    • Yuan, R.1    Madani, S.2    Wei, X.X.3    Reynolds, K.4    Huang, S.M.5
  • 41
    • 33748036988 scopus 로고    scopus 로고
    • Short-term antiviral activity of TMC278 - A novel NNRTI - In treatment-naive HIV1-infected subjects
    • F. Goebel, A. Yakovlev, A.L. Pozniak, E. Vinogradova, G. Boogaerts, and R. Hoetelmans Short-term antiviral activity of TMC278 - a novel NNRTI - in treatment-naive HIV1-infected subjects AIDS 20 2006 1721 1726
    • (2006) AIDS , vol.20 , pp. 1721-1726
    • Goebel, F.1    Yakovlev, A.2    Pozniak, A.L.3    Vinogradova, E.4    Boogaerts, G.5    Hoetelmans, R.6
  • 42
    • 77957328851 scopus 로고    scopus 로고
    • Pharmacokinetics of once-daily etravirine without and with once-daily darunavir/ritonavir in antiretroviral-naive HIV type-1-infected adults
    • E. DeJesus, J.P. Lalezari, O.O. Osiyemi, P.J. Ruane, R. Ryan, and T.N. Kakuda Pharmacokinetics of once-daily etravirine without and with once-daily darunavir/ritonavir in antiretroviral-naive HIV type-1-infected adults Antivir Ther 15 2010 711 720
    • (2010) Antivir Ther , vol.15 , pp. 711-720
    • Dejesus, E.1    Lalezari, J.P.2    Osiyemi, O.O.3    Ruane, P.J.4    Ryan, R.5    Kakuda, T.N.6
  • 43
    • 84858002034 scopus 로고    scopus 로고
    • Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among HIV-treated Ugandans
    • S. Nanzigu, J. Eriksen, F. Makumbi, S. Lanke, M. Mahindi, and R. Kiguba Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among HIV-treated Ugandans HIV Med 13 2012 193 201
    • (2012) HIV Med , vol.13 , pp. 193-201
    • Nanzigu, S.1    Eriksen, J.2    Makumbi, F.3    Lanke, S.4    Mahindi, M.5    Kiguba, R.6
  • 44
    • 33646693667 scopus 로고    scopus 로고
    • Synthetic drugs and natural products as modulators of constitutive androstane receptor (CAR) and pregnane X receptor (PXR)
    • T.K.H. Chang, and D.J. Waxman Synthetic drugs and natural products as modulators of constitutive androstane receptor (CAR) and pregnane X receptor (PXR) Drug Metab Rev 38 2006 51 73
    • (2006) Drug Metab Rev , vol.38 , pp. 51-73
    • Chang, T.K.H.1    Waxman, D.J.2
  • 45
    • 1642454581 scopus 로고    scopus 로고
    • Identification of amino acids in rat pregnane X receptor that determine species-specific activation
    • R.G. Tirona, B.F. Leake, L.M. Podust, and R.B. Kim Identification of amino acids in rat pregnane X receptor that determine species-specific activation Mol Pharmacol 65 2004 36 44
    • (2004) Mol Pharmacol , vol.65 , pp. 36-44
    • Tirona, R.G.1    Leake, B.F.2    Podust, L.M.3    Kim, R.B.4
  • 46
    • 0036401086 scopus 로고    scopus 로고
    • Identification of residues in the PXR ligand binding domain critical for species specific and constitutive activation
    • T. Ostberg, G. Bertilsson, L. Jendeberg, A. Berkenstam, and J. Uppenberg Identification of residues in the PXR ligand binding domain critical for species specific and constitutive activation Eur J Biochem 269 2002 4896 4904
    • (2002) Eur J Biochem , vol.269 , pp. 4896-4904
    • Ostberg, T.1    Bertilsson, G.2    Jendeberg, L.3    Berkenstam, A.4    Uppenberg, J.5
  • 47
    • 13244298263 scopus 로고    scopus 로고
    • Simultaneous substitution of phenylalanine-305 and aspartate-318 of rat pregnane X receptor with the corresponding human residues abolishes the ability to transactivate the CYP3A23 promoter
    • X. Song, Y. Li, J. Liu, M. Mukundan, and B. Yan Simultaneous substitution of phenylalanine-305 and aspartate-318 of rat pregnane X receptor with the corresponding human residues abolishes the ability to transactivate the CYP3A23 promoter J Pharmacol Exp Ther 312 2005 571 582
    • (2005) J Pharmacol Exp Ther , vol.312 , pp. 571-582
    • Song, X.1    Li, Y.2    Liu, J.3    Mukundan, M.4    Yan, B.5
  • 48
    • 78049359694 scopus 로고    scopus 로고
    • A 96-well plate assay for CYP4503A induction using cryopreserved human hepatocytes
    • N. Kamiguchi, E. Aoyama, T. Okuda, and T. Moriwaki A 96-well plate assay for CYP4503A induction using cryopreserved human hepatocytes Drug Metab Dispos 38 2010 1912 1916
    • (2010) Drug Metab Dispos , vol.38 , pp. 1912-1916
    • Kamiguchi, N.1    Aoyama, E.2    Okuda, T.3    Moriwaki, T.4
  • 49
    • 77953243792 scopus 로고    scopus 로고
    • Impact of ritonavir, atazanavir and their combination on the CYP3A4 induction potential of efavirenz in primary human hepatocytes
    • G.M. Mugundu, N. Hariparsad, and P.B. Desai Impact of ritonavir, atazanavir and their combination on the CYP3A4 induction potential of efavirenz in primary human hepatocytes Drug Metab Lett 4 2010 45 50
    • (2010) Drug Metab Lett , vol.4 , pp. 45-50
    • Mugundu, G.M.1    Hariparsad, N.2    Desai, P.B.3
  • 50
    • 79955526585 scopus 로고    scopus 로고
    • Pharmacokinetic interactions of maraviroc with darunavir-ritonavir, etravirine, and etravirine-darunavir-ritonavir in healthy volunteers: Results of two drug interaction trials
    • T.N. Kakuda, S. Abel, J. Davis, J. Hamlin, M. Scholler-Gyure, and R. Mack Pharmacokinetic interactions of maraviroc with darunavir-ritonavir, etravirine, and etravirine-darunavir-ritonavir in healthy volunteers: results of two drug interaction trials Antimicrob Agents Chemother 55 2011 2290 2296
    • (2011) Antimicrob Agents Chemother , vol.55 , pp. 2290-2296
    • Kakuda, T.N.1    Abel, S.2    Davis, J.3    Hamlin, J.4    Scholler-Gyure, M.5    MacK, R.6
  • 51
    • 84869119409 scopus 로고    scopus 로고
    • Bumpus NN. Cytochrome P450 3A5 plays a prominent role in the oxidative metabolism of the anti-human immunodeficiency virus drug maraviroc
    • Y. Lu, and C.W. Hendrix Bumpus NN. Cytochrome P450 3A5 plays a prominent role in the oxidative metabolism of the anti-human immunodeficiency virus drug maraviroc Drug Metab Dispos 40 2012 2221 2230
    • (2012) Drug Metab Dispos , vol.40 , pp. 2221-2230
    • Lu, Y.1    Hendrix, C.W.2
  • 53
    • 84857233202 scopus 로고    scopus 로고
    • Induction of CYP2C19 and CYP3A activity following repeated administration of efavirenz in healthy volunteers
    • V. Michaud, E. Ogburn, N. Thong, A.O. Aregbe, T.C. Quigg, and D.A. Flockhart Induction of CYP2C19 and CYP3A activity following repeated administration of efavirenz in healthy volunteers Clin Pharmacol Ther 91 2012 475 482
    • (2012) Clin Pharmacol Ther , vol.91 , pp. 475-482
    • Michaud, V.1    Ogburn, E.2    Thong, N.3    Aregbe, A.O.4    Quigg, T.C.5    Flockhart, D.A.6
  • 54
    • 45849151673 scopus 로고    scopus 로고
    • CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4-beta-hydroxycholesterol levels
    • F. Josephson, L. Bertilsson, Y. Bottiger, L. Flamholc, M. Gisslen, and V. Ormaasen CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4-beta-hydroxycholesterol levels Eur J Clin Pharmacol 64 2008 775 781
    • (2008) Eur J Clin Pharmacol , vol.64 , pp. 775-781
    • Josephson, F.1    Bertilsson, L.2    Bottiger, Y.3    Flamholc, L.4    Gisslen, M.5    Ormaasen, V.6
  • 55
    • 33748278051 scopus 로고    scopus 로고
    • Effect of widely used combinations of antiretroviral therapy on liver CYP3A4 activity in HIV-infected patients
    • S. Mouly, N. Rizzo-Padoin, G. Simoneau, C. Verstuyft, G. Aymard, and C. Salvat Effect of widely used combinations of antiretroviral therapy on liver CYP3A4 activity in HIV-infected patients Br J Clin Pharmacol 62 2006 200
    • (2006) Br J Clin Pharmacol , vol.62 , pp. 200
    • Mouly, S.1    Rizzo-Padoin, N.2    Simoneau, G.3    Verstuyft, C.4    Aymard, G.5    Salvat, C.6
  • 56
    • 12644270207 scopus 로고    scopus 로고
    • Steady-state pharmacokinetics of delavirdine in HIV-positive patients: Effect on erythromycin breath test
    • C.L. Cheng, D.E. Smith, P.L. Carver, S.R. Cox, P.B. Watkins, and D.S. Blake Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test Clin Pharmacol Ther 61 1997 531 543
    • (1997) Clin Pharmacol Ther , vol.61 , pp. 531-543
    • Cheng, C.L.1    Smith, D.E.2    Carver, P.L.3    Cox, S.R.4    Watkins, P.B.5    Blake, D.S.6
  • 57
    • 0032454713 scopus 로고    scopus 로고
    • Microsomal metabolism of delavirdine: Evidence for mechanism-based inactivation of human cytochrome P450 3A
    • R.L. Voorman, S.M. Maio, N.A. Payne, Z. Zhao, K.A. Koeplinger, and X. Wang Microsomal metabolism of delavirdine: evidence for mechanism-based inactivation of human cytochrome P450 3A J Pharmacol Exp Ther 287 1998 381 388
    • (1998) J Pharmacol Exp Ther , vol.287 , pp. 381-388
    • Voorman, R.L.1    Maio, S.M.2    Payne, N.A.3    Zhao, Z.4    Koeplinger, K.A.5    Wang, X.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.